MINH TAM HO: Open Payments
NPI 1700288479 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,381 in 101 payments from 16 companies in 2025. Trend: 2023 $1,352 · 2024 $842 · 2025 $2,381
Food & beverage: $2,326Education: $55
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $726 |
| Neurocrine BioSciences, Inc. | 26 | $261 |
| Novartis Pharmaceuticals Corporation | 13 | $240 |
| HARMONY BIOSCIENCES LLC | 10 | $195 |
| UCB, Inc. | 8 | $193 |
| ARGENX US, INC. | 8 | $174 |
| EMD Serono, Inc. | 6 | $161 |
| Biogen, Inc. | 4 | $83 |
| Lilly USA, LLC | 3 | $81 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
Products named: INSPIRE, INGREZZA, KESIMPTA, VYVGART HYTRULO, WAKIX, Briviact, Nayzilam, ZEPBOUND.
Industry payments across LA — which companies pay providers there.
